Importantly, our results further our understanding of the mechanisms by which sGC activity is regulated and provide new routes for rational design of small molecules that target these allosteric regions to improve dysfunctional sGC activity in cardiovascular diseases. Here, SGCB is linked to cardiovascular disorder.